Diabetes mellitus, type 2 is a medical condition with active clinical research programs worldwide.

50 total trials for this combination

Showing top 10 of 50 trials

Trials

NCT ID	Title	Status	Phase
NCT07064473	EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	RECRUITING	—
NCT07064473	EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	RECRUITING	—
NCT00968708	Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome	COMPLETED	PHASE3
NCT01336023	Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes	COMPLETED	PHASE3
NCT07064473	EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	RECRUITING	—
NCT06066528	A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight	COMPLETED	—
NCT01243424	CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes	COMPLETED	PHASE3
NCT01370005	12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus	COMPLETED	PHASE3
NCT00279045	Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide	COMPLETED	PHASE3
NCT01991795	A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus	COMPLETED	PHASE3

Related Pages

All Diabetes mellitus, type 2 trials All trials in Helsinki, Finland